PrimaryLogo_Mango-05.png
MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY
13 févr. 2024 08h00 HE | Mangoceuticals, Inc.
San Francisco Fans Nationwide Get Three Free Mangorx ED Pills Based on Sunday’s Game Point Difference Dallas, Texas, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX)...
PrimaryLogo_Mango-05.png
Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering
15 déc. 2023 10h39 HE | Mangoceuticals, Inc.
Dallas, Texas, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
PrimaryLogo_Mango-05.png
MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT
13 déc. 2023 07h30 HE | Mangoceuticals, Inc.
The Dallas Based, Direct-to-Consumer Telemedicine Company Secures Marketing Agreement with Marius Pharmaceuticals Bringing KYZATREX to the Telehealth Market as ‘Prime’ by MangoRx Dallas, Texas...